Zapata Quantum

Zapata Quantum

Delivers industrial-scale generative AI solutions

Overview

Zapata AI provides industrial generative AI software for large enterprises and government agencies. Its core product, the Orquestra platform, is a software stack that accelerates AI/ML development and deployment by using quantum-inspired techniques on standard CPUs and GPUs in a hardware-agnostic way. It differentiates itself by translating quantum algorithms research into enterprise-grade software that runs on conventional hardware and supports edge and on-premises deployments for industries like defense, manufacturing, finance, and automotive. Its goal is to commercialize quantum-inspired methods to scale AI across industry, grow as a public company, and help customers optimize operations and decision-making.

About Zapata Quantum

Simplify's Rating
Why Zapata Quantum is rated
C-
Rated B on Competitive Edge
Rated C on Growth Potential
Rated D- on Differentiation

Industries

Data & Analytics

Government & Public Sector

Enterprise Software

AI & Machine Learning

Company Size

11-50

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

2017

Get referred to Zapata Quantum

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 2026 Triatomic-led financing raised $15 million after restructuring.
  • June 2026 NVIDIA collaboration automates quantum resource estimation for drug discovery.
  • August 2026 QuEra partnership targets enterprise use cases ahead of 2028 hardware.

What critics are saying

  • July 2026 S-1 shows $642 cash, $1.3 million quarterly loss, and going-concern warnings.
  • The S-1 also registers 56.8 million selling shares, signaling massive dilution.
  • October 2024 wind-down and March 2025 Nasdaq delisting prove the business already failed once.

What makes Zapata Quantum unique

  • Only DARPA Quantum Benchmarking participant across all technical areas, with 60-plus patents.
  • Hardware-agnostic software targets quantum applications before fault-tolerant machines arrive.
  • Nature Biotechnology named its 2025 drug-discovery paper a Top 10 paper.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$296.3M

Above

Industry Average

Funded Over

10 Rounds

Post IPO Equity funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Equity Funding Comparison
Coming Soon

Stock Price

Growth & Insights and Company News

Headcount

6 month growth

-9%

1 year growth

-16%

2 year growth

-16%
CFOTech
Aug 12th, 2026
Zapata partners QuEra to develop quantum use cases.

Zapata partners QuEra to develop quantum use cases. Wed, 12th Aug 2026 (Yesterday) Zapata Quantum has partnered with QuEra to develop quantum computing use cases aimed at improving the commercial prospects for applications before fully fault-tolerant hardware becomes available. The work will combine QuEra's neutral-atom quantum computing roadmap with Zapata's focus on algorithms and application development. The goal is to address a gap between advances in quantum hardware and the availability of practical business applications. Under the arrangement, Zapata will help identify the enterprise use cases that matter most, assess when they may become practical, and develop the applications and algorithms needed to run on future systems. The partnership also supports QuEra's work with enterprises, government programmes and high-performance computing centres seeking to design and validate applications ahead of full fault tolerance. The tie-up sits within the QuEra Quantum Alliance Program, which is intended to bring together organisations working across different parts of the quantum stack. For QuEra, it adds an application development partner as the company pursues a roadmap towards a fault-tolerant machine accessible through AWS. Quantum computing companies have increasingly shifted attention from headline hardware milestones to the harder question of whether customers will have useful tasks ready when larger, more reliable systems arrive. That has pushed software specialists and hardware developers into closer partnerships, particularly in pharmaceuticals, finance, materials and defence, where advocates argue quantum systems could eventually tackle problems that are difficult for classical machines. Zapata describes itself as hardware-agnostic, developing software and applications designed to work across different quantum approaches rather than for a single machine design. QuEra, by contrast, is focused on neutral-atom quantum computing, one of several competing architectures being pursued across the industry. Neutral-atom systems use individual atoms as qubits and have drawn attention as one possible route to scaling quantum processors. QuEra traces its roots to research at Harvard and MIT and operates from Boston, New Mexico, Tokyo, Zurich and the United Kingdom. For Zapata, the partnership adds to a broader strategy of aligning with larger technology groups and quantum hardware companies. The company recently announced an ongoing partnership with NVIDIA focused on applying agentic AI to quantum algorithm development, underscoring its effort to combine quantum software research with advances in artificial intelligence. The commercial question remains central to both companies' message. Quantum hardware has made technical progress, but fully fault-tolerant systems capable of running complex workloads reliably are still under development, leaving many prospective users uncertain about when to invest in application design and where to focus their efforts. Roadmap focus QuEra is working towards a megaquop-class system through AWS in 2028, a milestone that gives application developers a target for planning. In the meantime, partnerships like this are intended to ensure useful workloads are tested and refined before the hardware reaches that stage. Zapata says its work spans cryptography, pharmaceuticals, finance, materials discovery and defence. It also says it has participated across all technical areas of DARPA's Quantum Benchmarking programme and has worked with Fortune 500 companies and government agencies on quantum-related projects. Its research profile received a boost when a study on quantum-enabled drug discovery was recognised as one of Nature Biotechnology's Top 10 Papers of 2025. That supports the company's pitch to customers as a group seeking to connect theoretical quantum advances with specific industry tasks. QuEra has made a similar case for practical preparation, arguing that customers should begin co-designing applications before large-scale fault-tolerant machines are ready. The latest partnership reflects that approach by pairing a hardware developer with a software company specialising in identifying and shaping potential workloads. Sumit Kapur, Chief Executive Officer of Zapata Quantum, outlined that view in the company's announcement. "QuEra's commitment to delivering a megaquop-class system via AWS in 2028 is exciting for the field and something we're looking forward to supporting from the application side," Kapur said. "We are uniquely positioned as a hardware-agnostic partner to help enterprises identify which quantum use cases matter, assess when they will become viable, and develop the applications and algorithms needed to drive transformational business value as these systems come online," he added. Yuval Boger, Chief Commercial Officer at QuEra Computing, said the company sees application work as integral to making quantum systems useful to customers. "By pairing QuEra's leadership in fault-tolerant quantum computing with Zapata's focus on application development, we can further accelerate the path from quantum capability to commercial value," Boger said.

Yahoo Finance
Jul 7th, 2026
Zapata Quantum CEO to present at Global Technology conference, highlights NVIDIA collaboration and Nature Top 10 cancer research

Zapata Quantum announced that CEO Sumit Kapur will present at the Global Technology Virtual Investor Conference on 9 July. Kapur will discuss the company's collaboration with NVIDIA on applying agentic AI to quantum algorithm development and its quantum cancer research, recognised as a Nature Biotechnology Top 10 paper of 2025. The Boston-based quantum software company recently completed a $15 million fundraise led by Triatomic Capital. The study, co-authored with Dana-Farber Cancer Institute, University of Toronto, and Insilico Medicine, demonstrated quantum computing's potential in drug discovery. Zapata has expanded its leadership team with Yudong Cao, former Head of Quantum at BCG X, joining as CTO.

Quantum Computing Report
Jun 23rd, 2026
Zapata Quantum and NVIDIA integrate agentic AI to automate quantum resource estimation.

Zapata Quantum and NVIDIA integrate agentic AI to automate quantum resource estimation. Zapata Quantum and NVIDIA have partnered to integrate agentic AI into quantum algorithm development by automating quantum resource estimation workflows. The collaboration focuses on streamlining a process used to determine the exact hardware specifications, error-correction budgets, and physical execution times required to run quantum applications. Initial engineering efforts are directed at complex quantum chemistry challenges, including pharmaceutical drug discovery, energy grid optimization, and advanced materials development, where benchmarking quantum algorithms has historically stood as a significant developer bottleneck. Conventional algorithm benchmarking and resource estimation typically require extensive multi-year efforts from domain experts spanning molecular modeling, software compilation, and hardware architecture evaluation. The joint workflow compresses this timeline by implementing an orchestrated multi-agent AI framework designed to automate these separate steps into a scalable system. The automated pipeline utilizes the NVIDIA Agent Toolkit software to establish tracking, observation, and operational guardrails for the underlying multi-agent AI setup, combining continuously verified software compilation layers with predictive models capable of calculating physical qubit counts and gate depths before a computation is initiated on live hardware backends. The cooperative methodology has been validated by testing its automated estimation protocols on homogeneous catalysis, building on Zapata's previous benchmarking datasets created during its participation across all technical segments of the DARPA Quantum Benchmarking program. Homogeneous catalysis presents a significant computational bottleneck for classical simulation, making it a critical test case for verifying how effectively the automated framework can identify high-value industrial workloads. To secure the intellectual property of this verification-aware automation approach, Zapata has also filed a provisional patent application detailing the implementation of its agentic framework for quantum computing applications. The official corporate disclosure detailing the technical collaboration, software workflows, and patent filings can be reviewed directly via the Zapata Quantum Investor Relations Portal here. June 23, 2026

The Quantum Insider
Jun 23rd, 2026
Zapata Quantum teams with NVIDIA to apply agentic AI to accelerate quantum algorithm development.

Zapata Quantum teams with NVIDIA to apply agentic AI to accelerate quantum algorithm development. Insider Brief * Zapata Quantum is working with NVIDIA to apply agentic AI to automate quantum resource estimation workflows, initially targeting quantum chemistry applications in drug discovery, energy and advanced materials. * The collaboration is designed to reduce the expert time and cost required to benchmark quantum algorithms by combining AI orchestration, verified quantum workflows and feasibility models that estimate hardware needs before computation. * Zapata said the approach has been tested in homogeneous catalysis, building on its DARPA Quantum Benchmarking work, and the company has filed a provisional patent application for an "agentic framework for quantum." PRESS RELEASE - Zapata Quantum (OTCQB: ZPTA) ("Zapata" or the "Company") today announced it is applying agentic AI to accelerate quantum algorithm development by automating quantum resource estimation ("QRE") workflows, in collaboration with NVIDIA. The effort initially targets applications in quantum chemistry, including drug discovery, energy, and advanced materials development. "We believe that automation, powered by advances in AI and informed by domain-specific knowledge, is the key to scaling quantum application development for real-world applications such as drug discovery," said Yudong Cao, Zapata's Chief Technology Officer. "By working alongside NVIDIA, we're applying agentic AI to address the challenge of efficiently benchmarking quantum algorithms, an underappreciated bottleneck in quantum application development." Orchestrated Multi-Agentic AI Solution Today, the benchmarking of a single class of quantum algorithms often involves years of expert effort spanning molecular modeling, algorithm design, and hardware resource estimation. Zapata and NVIDIA are collaborating on an agentic AI workflow designed to compress this process into a scalable automated system to significantly lower the cost and time required. "Agentic AI is proving transformative in shortening the timeline to useful quantum applications," said Sam Stanwyck, Director of Quantum Product at NVIDIA. "This work with Zapata shows how crucial accelerated computing and AI is for practical and scalable quantum resource estimation, and how impactful that can be for developing meaningful applications in areas such as industrial quantum chemistry." The workflow combines AI orchestration, continuously verified quantum workflows, and an AI feasibility model capable of predicting hardware requirements before computation begins. The approach utilizes NVIDIA Agent Toolkit software to provide guardrails and monitoring for the workflow's initial multi-agentic setup. Approach Tested with Homogeneous Catalysis The initiative has already demonstrated the potential of the approach in the field of homogeneous catalysis, building on Zapata's prior work in the same area as part of the DARPA Quantum Benchmarking program. Homogeneous catalysis is a computationally demanding and strategically important quantum chemistry problem given its applicability to high-value areas such as pharmaceuticals, energy and advanced materials. The team of scientists from both companies now seeks to refine the methodology and broaden its application within quantum chemistry. Zapata also recently filed a provisional patent application related to an "agentic framework for quantum," reflecting the company's broader verification-aware AI approach to scalable quantum application development. "The future of quantum computing will not be determined solely by hardware progress but by our ability to systematically discover, evaluate, and develop high-value applications," said Cao. "AI has the potential to do for quantum application development what modern software tools have done for traditional software engineering - enabling researchers to move faster, explore more ideas, and focus their expertise where it creates the most value." Matt Swayne. With a several-decades long background in journalism and communications, Matt Swayne has worked as a science communicator for an R1 university for more than 12 years, specializing in translating high tech and deep tech for the general audience. He has served as a writer, editor and analyst at The Quantum Insider since its inception. In addition to his service as a science communicator, Matt also develops courses to improve the media and communications skills of scientists and has taught courses. [email protected]. Relevant. Matt Swayne May 12, 2026 Matt Swayne August 5, 2022 Matt Swayne October 23, 2020 Matt Swayne August 12, 2024 Mohib Ur Rehman January 23, 2026

Yahoo Finance
Jun 23rd, 2026
Zapata Quantum and NVIDIA deploy agentic AI to automate quantum algorithm development

Zapata Quantum is collaborating with NVIDIA to apply agentic AI to automate quantum resource estimation workflows, targeting applications in quantum chemistry, drug discovery, energy and advanced materials development. The initiative aims to address a major bottleneck in quantum algorithm development. The companies are developing an automated system that combines AI orchestration, verified quantum workflows and AI feasibility modelling using NVIDIA Agent Toolkit software. The approach has been tested in homogeneous catalysis, building on Zapata's work from the DARPA Quantum Benchmarking programme. Zapata has filed a provisional patent application related to an "agentic framework for quantum". The company, which trades on OTCQB under ticker ZPTA, holds over 60 granted and pending patents in quantum software and participates across all technical areas of DARPA's Quantum Benchmarking programme.

Recently Posted Jobs

Sign up to get curated job recommendations

Zapata Quantum is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →